Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility

NCT01729533 is registered in ClinicalTrials.gov with Sapientiae Institute as lead sponsor.

NCT NCT01729533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01729533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility
Lead sponsor
Sapientiae Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2012
Completion date
February 28, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy